Orthopedic, Prosthetic & Surgical Appliances & Supplies
A source-attributed, AI-written analyst report for STE.
Every figure is drawn from public filings — the AI writes the analysis, never the numbers.
How the company returns cash to shareholders — from its latest annual SEC filings.
Annual figures from SEC filings · descriptive, not a dividend-safety rating or advice. Delayed data.
Daily OHLC · MA/MACD/RSI computed locally. Not investment advice.
Reference figures from the latest SEC filings (FY2026).
| Market cap | $22.30B |
|---|---|
| P/E (TTM) | 28.8 |
| P/B | 3.10 |
| Dividend yield | 1.08% |
| Revenue (TTM) | $5.94B |
| Rev. growth (YoY) | +8.7% |
| Net income (TTM) | $782.30M |
| Net margin (TTM) | 13.2% |
| EPS, diluted (TTM) | $7.93 |
| 52-week range | $195.14 – $269.44 |
| Next earnings | Aug 4, 2026 |
Figures from SEC filings · delayed prices · for reference only · not investment advice
Try one backtest free — see how the golden-cross signal performed on this stock.
Sign in to run a free backtestHistorical statistic over past daily data — how this rule behaved before, not a prediction or advice.
Trailing return vs the S&P 500 (SPY) — positive means it outperformed the market.
Trailing price performance vs SPY — a disclosed historical statistic, not a forecast or advice. Delayed data.
How the price has historically moved around past earnings announcements.
A ~2-session move spanning each earnings date — a disclosed historical statistic, not a forecast or advice. Delayed data.
Percentile rank vs Tickwind’s tracked universe — higher = stronger on that factor.
Percentile rank vs Tickwind’s tracked universe. The letter grades are a plain relabeling of these descriptive percentiles; the headline Quant Rating is a disclosed mechanical mapping of the composite percentile — a relative quantitative signal, not personalized investment advice. Delayed data.
Two published academic scores computed from SEC filings — itemized, descriptive, not a rating.
Computed from SEC XBRL filings via published academic formulas (Piotroski 2000; Altman 1968). Zone names are the papers’ published band labels. Descriptive — not a rating, prediction, or investment advice.
Average return by calendar month over the available years.
Historical average monthly returns — a disclosed statistic, not a forecast or advice. Delayed data.
Log in to track STE and save links
Keep a watchlist and clip posts from anywhere — free.
Latest SEC filings and headlines for STERIS plc (STE).
Steris (STE) Stock After Q4 Miss And 2027 Outlook What The Valuation Signals Now
Yahoo · Jun 12, 2026
[Latest] Global Gastrointestinal Endoscopy Devices Market Size/Share Worth USD 19.6 Billion by 2035 at a 5.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)
Yahoo · Jun 10, 2026
Why Is Steris (STE) Up 1% Since Last Earnings Report?
Yahoo · Jun 10, 2026
Figures from SEC filings · delayed prices · for reference only · not investment advice